US Broker Ratings

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unpacking the Potential of a Biotech Pioneer with 83.9% Revenue Growth

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a commercial-stage biopharmaceutical company based in Brisbane, California, is making waves in the biotechnology sector with an impressive 83.9% revenue growth. Specializing in the..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 58.63% Potential Upside in the Biotech Sector

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biotechnology industry, is capturing the attention of investors with its promising drug pipeline and a significant potential upside of 58.63%...

Neuropace, Inc. (NPCE) Stock Analysis: Exploring a 45.50% Potential Upside

Neuropace, Inc. (NASDAQ: NPCE), a key player in the healthcare sector, specifically within the medical devices industry, is catching investor attention with a compelling potential upside of 45.50%. Headquartered in..

Trevi Therapeutics, Inc. (TRVI) Investor Outlook: An 82.59% Potential Upside Sparks Interest

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is currently making waves in the biotechnology industry. With a robust market capitalization of $1.52 billion,..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a Complex Landscape with 47% Revenue Growth

Investors with an eye on Cronos Group Inc. (NASDAQ: CRON) are witnessing an intriguing narrative unfold in the burgeoning cannabis sector. As a key player in the healthcare industry, specifically..

Butterfly Network, Inc. (BFLY) Stock Analysis: Unpacking a 34% Potential Upside in the Healthcare Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices industry, has been capturing investor attention with its promising potential upside of 34.04%. Headquartered in Burlington, Massachusetts, the..

Iovance Biotherapeutics, Inc. (IOVA): Investor Outlook with 143.90% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector with its promising outlook for investors. With a market capitalization of $1.52 billion, Iovance is positioned at the..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 251% Potential Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS) is a name that might not instantly ring a bell for every investor, yet it has carved a niche for itself within the vibrant healthcare sector,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Potential Forward P/E of 11.08

Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical devices sector, offers investors a unique blend of opportunities and challenges. With a market capitalization of $644.13 million, this..

AnaptysBio, Inc. (ANAB) Investor Outlook: Unlocking 20% Upside Potential in Biotechnology

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company rooted in the heart of San Diego, California, is capturing the attention of investors with its robust pipeline and impressive growth metrics...

Nuvation Bio Inc. (NUVB) Stock Analysis: 161% Potential Upside Beckons Investors

Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, has captured investor attention with a striking potential upside of 161.44%. This clinical-stage biopharmaceutical company is on an..

RxSight, Inc. (RXST) Stock Analysis: Navigating Challenges with a 57% Potential Upside

RxSight, Inc. (NASDAQ: RXST), a pioneering medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery, finds itself at a crucial juncture. With a current market capitalization..

Savara, Inc. (SVRA) Investor Outlook: Biotech Stock with Over 100% Potential Upside

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention as it targets rare respiratory diseases. With a market capitalization of $1.07 billion, the company is focused on..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a Potential 181% Upside in the Biotechnology Sector

For investors with an eye on the biotechnology sector, Bicycle Therapeutics plc (NASDAQ: BCYC) presents an intriguing opportunity. With a market capitalization of $313.68 million and a substantial potential upside..

Maravai LifeSciences Holdings (MRVI): Investor Outlook Unveils 40% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a San Diego-based biotechnology company, is capturing investor attention with a notable potential upside of 40.24%, as suggested by its current analyst ratings. Despite..

Sionna Therapeutics, Inc. (SION)

⚠️ No article content returned.

..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a 396.96% Potential Upside

For investors seeking a high-risk, high-reward opportunity within the biotechnology sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) presents a compelling case. This innovative company, headquartered in Solana Beach, California, focuses on..

InMode Ltd. (INMD) Stock Analysis: Unlocking 23.64% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), an innovative player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a notable 23.64% potential upside, according to analyst targets...

Pharvaris N.V. (PHVS) Stock Analysis: Biotech Player with a 67.65% Potential Upside

Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is capturing investor attention with its promising potential upside of 67.65%. Specializing in therapies for rare bradykinin-mediated diseases, Pharvaris is advancing its late-stage..

Xeris Biopharma Holdings (XERS) Stock Analysis: Potential 100% Upside Beckons Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing investor attention with a potential upside of 100.05%, as highlighted by recent analyst ratings. This Chicago-based biopharmaceutical company is dedicated to advancing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds